## Core Concept
Thorium dioxide, also known as thorotrast, is a radioactive contrast agent that was historically used in radiology. Its use has been discontinued due to its radioactive properties and the severe health complications associated with its administration. The primary concern with thorium dioxide is its **radioactive decay** and the resultant **radiation-induced damage** to tissues.

## Why the Correct Answer is Right
Thorium dioxide causes **α-particle radiation**, which is highly ionizing and can cause significant damage to tissues, leading to **radiation-induced fibrosis** and **increased risk of malignancy**. When thorium dioxide decays, it releases α-particles, which have a short range but are highly effective at causing damage to cells and tissues. This results in chronic inflammation, fibrosis, and an increased risk of cancer in the affected areas.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because, although thorium dioxide does cause tissue damage, the specific association with **α-particle emission** is what leads to its harmful effects.
- **Option B:** This option is incorrect because, while **γ radiation** is a form of ionizing radiation, thorium dioxide primarily causes damage through **α-particle emission**.
- **Option C:** This option might seem plausible but is incorrect because the primary concern with thorium dioxide is not **neutron emission** but **α-particle radiation**.

## Clinical Pearl / High-Yield Fact
A key point to remember is that thorium dioxide (thorotrast) was used as a contrast agent in the past but is no longer used due to its association with **radiation-induced liver disease** and **malignancy**. Its use has been replaced by safer, non-radioactive contrast agents.

## Correct Answer Line
**Correct Answer: D.**